Direct-acting antiviral retreatment patterns for hepatitis C

BACKGROUND: Despite the strong efficacy of direct-acting antivirals (DAAs) against the hepatitis C virus, many patients require a second regimen of DAA treatment. However, limited research exists to characterize rates of retreatment across different DAA agents or potential factors that may increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Shaquib Al, Dauner, Daniel G, Rajpurohit, Abhijeet, Farley, Joel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372973/
https://www.ncbi.nlm.nih.gov/pubmed/36125057
http://dx.doi.org/10.18553/jmcp.2022.28.10.1100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372973/
https://www.ncbi.nlm.nih.gov/pubmed/36125057
http://dx.doi.org/10.18553/jmcp.2022.28.10.1100

Ejemplares similares